1. Overview of the mammalian ADP-ribosyl-transferases clostridia toxin-like (ARTCs) family
    Maria Di Girolamo et al, 2019, Biochemical Pharmacology CrossRef
  2. ART1 knockdown decreases the IL-6-induced proliferation of colorectal cancer cells
    Ting Lin et al, 2024, BMC Cancer CrossRef
  3. A novel conserved family of Macro-like domains—putative new players in ADP-ribosylation signaling
    Małgorzata Dudkiewicz et al, 2019, PeerJ CrossRef
  4. Molecular pathogenesis of subretinal fibrosis in neovascular AMD focusing on epithelial-mesenchymal transformation of retinal pigment epithelium
    Dandan Liu et al, 2023, Neurobiology of Disease CrossRef
  5. miR-335-5p inhibits TGF-β1-induced epithelial–mesenchymal transition in non-small cell lung cancer via ROCK1
    Wenwen Du et al, 2019, Respiratory Research CrossRef
  6. HIV-1 Reverse Transcriptase Expression in HPV16-Infected Epidermoid Carcinoma Cells Alters E6 Expression and Cellular Metabolism, and Induces a Hybrid Epithelial/Mesenchymal Cell Phenotype
    Alla Zhitkevich et al, 2024, Viruses CrossRef
  7. Recurrent HBV Integration Targets as Potential Drivers in Hepatocellular Carcinoma
    Selena Y. Lin et al, 2021, Cells CrossRef
  8. Identification of the role of mono-ADP-ribosylation in colorectal cancer by integrated transcriptome analysis
    Shuxian Zhang et al, 2021, Medical Oncology CrossRef
  9. ADP-Ribosylation as Post-Translational Modification of Proteins: Use of Inhibitors in Cancer Control
    Palmiro Poltronieri et al, 2021, International Journal of Molecular Sciences CrossRef
  10. Deleted in liver cancer 1 suppresses the growth of prostate cancer cells through inhibiting Rho-associated protein kinase pathway
    Hua Gong et al, 2023, Asian Journal of Urology CrossRef
  11. Dual regulatory role of CCNA2 in modulating CDK6 and MET‐mediated cell‐cycle pathway and EMT progression is blocked by miR‐381‐3p in bladder cancer
    Jiangfeng Li et al, 2019, The FASEB Journal CrossRef
  12. Nc886 promotes renal cancer cell drug-resistance by enhancing EMT through Rock2 phosphorylation-mediated β-catenin nuclear translocation
    Weiyin Gao et al, 2022, Cell Cycle CrossRef
  13. Effects of β-caryophyllene on arginine ADP-ribosyltransferase 1-mediated regulation of glycolysis in colorectal cancer under high-glucose conditions
    Li Zhou et al, 2018, International Journal of Oncology CrossRef

  14. Diosgenin and GSK126 Produce Synergistic Effects on Epithelial–Mesenchymal Transition in Gastric Cancer Cells by Mediating EZH2 via the Rho/ROCK Signaling Pathway


    Shanshan Liu et al, 2020, OncoTargets and Therapy CrossRef
  15. Emerging roles of ADP-ribosyl-acceptor hydrolases (ARHs) in tumorigenesis and cell death pathways
    Xiangning Bu et al, 2019, Biochemical Pharmacology CrossRef
  16. Inactivation of KDM5A suppresses growth and enhances chemosensitivity in liver cancer by modulating ROCK1/PTEN/AKT pathway
    Shiji Fang et al, 2023, European Journal of Pharmacology CrossRef
  17. Mono-ADP-ribosylation of histone 3 at arginine-117 promotes proliferation through its interaction with P300
    Feng Ling et al, 2017, Oncotarget CrossRef
  18. Kanglaite inhibits EMT caused by TNF-α via NF-κΒ inhibition in colorectal cancer cells
    Guiling Shi et al, 2018, Oncotarget CrossRef
  19. The interaction of Lin28A/Rho associated coiled-coil containing protein kinase2 accelerates the malignancy of ovarian cancer
    Yancheng Zhong et al, 2019, Oncogene CrossRef
  20. Analysis of the mechanism of aldo-keto reductase dependent cis-platin resistance in HepG2 cells based on transcriptomic and NADH metabolic state
    TINGTING SUN et al, 2023, BIOCELL CrossRef
  21. Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non–small cell lung cancer
    Erik Wennerberg et al, 2022, Science Translational Medicine CrossRef
  22. ARHGEF10L Promotes Cervical Tumorigenesis via RhoA-Mediated Signaling
    Junyi Tang et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef